Current Treatment Approaches in APL
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Recognize the current standard of treatment in the management of patients with APL, based on risk classification
Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center
- 0.50 Participation
- 0.51 Nurse
- 0.50 Pharmacist
- 0.50 Physician